Publications

Fernando Jesús Antoñanzas Villar publications

348 results

2026

  1. Multiple sclerosis treatment coverage: an analysis based on inequality indicators

    Revista de Saude Publica, Vol. 60

  2. Quality of Life Changes in Respiratory Infection Trajectory with Point of Care Testing During Clinical Consultation

    ClinicoEconomics and Outcomes Research , Vol. 18

2025

  1. Challenges in resource allocation of diagnostic tests in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research

  2. Equity in access to high-cost drugs for rare diseases in Brazil: dornase alfa case

    Journal of Pharmaceutical Health Services Research, Vol. 16, Núm. 4

2024

  1. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study

    PharmacoEconomics, Vol. 42, Núm. 2, pp. 219-229

  2. Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections-trial protocol for the ADEQUATE Paediatric trial

    BMJ Open, Vol. 14, Núm. 4

2023

  1. Cost of lost productivity from acute respiratory infections in South America

    Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 47

  2. Does diagnostic testing always decrease antibiotics prescriptions?

    European Journal of Health Economics, Vol. 24, Núm. 5, pp. 673-678

  3. EPH4 Burden of Disease and Cost of Permanent Productivity Loss of Cardiovascular Disease (CVD) in South America (SA)

    Value in Health

  4. Lost Productivity Attributed to Neoplasms in South America

    Revista Brasileira de Cancerologia, Vol. 69, Núm. 1

  5. Modelos dinámicos de transmisión

    Modelos analíticos de decisión en evaluación económica: tipos, metodología, análisis y comunicación de los resultados (Estudios Ediciones), pp. 371-393

  6. Tenders for generics and biosimilars: a challenging purchasing policy

    European Journal of Health Economics

  7. The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 23, Núm. 4, pp. 431-438

2022

  1. Burden of disease attributed to acute respiratory infections in South America

    Journal of Infection in Developing Countries, Vol. 16, Núm. 10, pp. 1614-1622

  2. Diagnostic testing for sepsis: A systematic review of economic evaluations

    Antibiotics, Vol. 11, Núm. 1

  3. Seeking efficiency gains outside drugs and diagnostics

    European Journal of Health Economics

2021

  1. A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  2. Analysis of the prescription of antibiotics during the implementation of COVID-19 personal protection measures in a regional health system

    ClinicoEconomics and Outcomes Research, Vol. 13, pp. 927-936

  3. Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars

    Advances in Rheumatology, Vol. 61, Núm. 1

  4. Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review

    PharmacoEconomics, Vol. 39, Núm. 12, pp. 1411-1427